Oncology

Latest News

The thinking around which patients are eligible for liver transplants needs to evolve, the authors noted, as the criteria used to evaluate fitness for transplant were proposed nearly three decades ago. | Image credit: Peakstock - stock.adobe.com

New Developments Warrant Rethinking HCC Transplant Criteria

By Jared Kaltwasser

April 29th 2025

Downstaging and bridging strategies are changing how hepatocellular carcinoma (HCC) is treated.

Women with fatigue | Image credit: Adobe Stock

Fatigue, Depression Hit Harder on Women Cancer Survivors, Data Show

By Mary Caffrey

April 29th 2025

senior scientist | Image credit: Ohio State University

Proving the Concept: A Sampler of Early-Stage Science at AACR 2025

By Mary Caffrey

April 28th 2025

NSCLC | Image: Lung Cancer Foundation of America

Zongertinib Shows Durable Responses With No Interstitial Lung Disease in HER2-Mutated Advanced NSCLC

By Mary Caffrey
Brooke McCormick

April 28th 2025

Considering the life-threatening risk of TLS, the researchers underscored the importance of identifying patients at particular risk of the complication. | Image credit: mi_viri - stock.adobe.com

Optimized Strategies Needed for TLS Prevention, Intervention in SCLC

By AJMC Contributor

April 23rd 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Watch Now

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

March 13th 2018

Pembrolizumab Granted Priority Review for Treatment of Cervical Cancer

Jaime Rosenberg

The FDA has accepted a new supplemental Biologics License Application and granted Priority Review for Merck's pembrolizumab (Keytruda) for the treatment of advanced cervical cancer, marking the first filing acceptance for an anti–PD-1 therapy in cervical cancer.

March 13th 2018

Dr Linda Frisk Discusses the Role of the Pharmacist in Value-Based Care

Linda Frisk, PharmD, of Arizona Oncology, discusses the role of the pharmacist in new value-based payment models and her experience with the Oncology Care Model (OCM).

March 13th 2018

ICER Outlines Planned Review of Antiandrogen Therapies for nmCRPC

Jaime Rosenberg

The Institute for Clinical and Economic Review (ICER) is requesting public comment on 3 antiandrogen therapies for nonmetastatic castrate-resistant prostate cancer (nmCRPC): abiraterone, enzalutamide, and apalutamide.

March 12th 2018

Dr Thomas Graf on the Impact of New Therapies in Oncology

Thomas Graf, MD, chief medical officer and vice president, Horizon Blue Cross Blue Shield of New Jersey, discusses the impact of increases in drug prices on oncology stakeholders.

March 10th 2018

Podcast: This Week in Managed Care—Verma on Health Data and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

March 10th 2018

Dr Thomas LeBlanc: Patients With Blood Cancer and Palliative Care

Thomas LeBlanc, MD, Duke Cancer Institute, discusses the trends of hospice care services used among patients with blood cancer compared with patients with solid tumors.

March 10th 2018

Tapping Into the Health Benefits of Social Networks Among Cancer Survivors

Surabhi Dangi-Garimella, PhD

Scientists at St. Jude Children’s Research Hospital have developed a new tool to measure the impact of social networks on the coping skills of adolescent and young adult cancer survivors.

March 10th 2018

Patients With Breast Cancer or Lymphoma Have Increased Risk of Heart Failure

Kaitlynn Ely

Patients who had breast cancer or lymphoma who were treated more than 3 times are more likely to develop congestive heart failure than those who did not have cancer, according to research being presented at the American College of Cardiology’s 67th Annual Scientific Session.

March 9th 2018

This Week in Managed Care: March 9, 2018

This week, the top managed care stories included Cigna's deal to buy Express Scripts; Seema Verma, Alex Azar, and Scott Gottlieb, MD, made the rounds at health conferences; an analysis finds FDA's accelerated approval pathway has been a success with hematology and oncology drugs.

March 8th 2018

Dr Adam Brufsky Outlines Care Coordination in Oncology

Care coordination is vital to ensure improved patient outcomes as both CMS and private payers are paying increased attention to it, pointed out Adam Brufsky, MD, PhD, co-director of the Comprehensive Breast Cancer Center at University of Pittsburgh. How is your institution infusing care coordination in its workflow?

March 8th 2018

Expedited Approval Is Successful for Cancer Therapies, FDA Says

Kelly Davio

Reviewing 25 years of experience with accelerated approvals (AAs) for malignant hematology and oncology drugs and biologics, FDA officials say that the AA program has demonstrated that it can be used successfully to expedite approval of safe, effective cancer therapies that balance uncertainty with the need to provide faster access to promising agents for serious and life-threatening diseases.

March 8th 2018

Science 37, Novartis Sign Agreement to Advance Decentralized Clinical Trials

AJMC Staff

Proprietary technology helps overcome the problem of long travel distances for those taking part in clinical trials.

March 7th 2018

FDA Authorizes Direct-to-Consumer Test That Reports on 3 BRCA Mutations

Jaime Rosenberg

The FDA has authorized, with special controls, the first direct-to-consumer test that reports on 3 specific BRCA1/BRCA2 breast cancer gene mutations that are most common in people of Ashkenazi (Eastern European) Jewish descent.

March 7th 2018

Impact of Trained Oncology Financial Navigators on Patient Out-of-Pocket Spending

Todd Yezefski, MD Jordan Steelquist, BA Kate Watabayashi, BA Dan Sherman, MA Veena Shankaran, MD

Hospitals that used trained financial navigators were able to provide financial assistance for their patients with cancer, providing access to care that would otherwise be unaffordable.

March 4th 2018

CSPG4 Could Make CAR T-Cell Therapy a Reality in Treating Glioblastoma

Kelly Davio

Researchers have identified a molecular target that could allow chimeric antigen receptor (CAR) T-cell therapy to be used in treating patients with glioblastoma. Although the heterogeneous expression of tumor-associated antigens limits the efficacy for CAR-redirected T cells for the treatment of glioblastoma, chondroitin sulfate proteoglycan 4 (CSPG4), a cell surface type 1 transmembrane protein, is highly expressed in a majority of glioblastoma specimens with limited heterogeneity.

March 4th 2018

Reacting to the Results of the First Performance Period of OCM

Laura Joszt, MA

The first results of the Oncology Care Model (OCM), a 5-year bundled payment demonstration from CMS, were released recently, and at a session at the National Community Oncology Dispensing Association Spring Forum 2018, Mike Fazio of Archway Health discussed the reconciliation statements from the first performance period of OCM, and where practices can look to make improvements going forward.

March 3rd 2018

Pain Management in Cancer and the Risk of Patients Developing Opioid Use Disorder

Laura Joszt, MA

As cancer treatments improve and death rates decline, more patients survive who are at risk of becoming addicted to pain medications they were prescribed to treat their cancer-related pain, explained Merrill Norton, PharmD, NCAC II, CCS, CCDP-D, of the University of Georgia.

March 3rd 2018

Michele McCourt Discusses Growing Financial Hardships for Patients With Cancer

Patients with cancer, many who are older and on Medicare, are finding their medications are becoming unaffordable, Michele McCourt, senior director of the CancerCare Co-Payment Assistance Foundation, explained at the Cost-Sharing Roundtable, co-hosted by the Patient Access Network Foundation and The American Journal of Managed Care®.

March 3rd 2018

Podcast: This Week in Managed Care—Bipartisan Health Reform Outline and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

March 3rd 2018

Financial Burden an Unintended Outcome of Cancer Care

Surabhi Dangi-Garimella, PhD

K. Robin Yabroff, PhD, strategic director, Surveillance and Health Services Research Program, American Cancer Society, would like to see more longitudinal studies that can develop more informed policies to alleviate patient financial hardship. Yabroff was speaking at the Cost-Sharing Roundtable co-hosted by the Patient Access Network Foundation and The American Journal of Managed Care®.

March 3rd 2018

Addressing Financial Concerns at the Outset to Improve Patient Outcomes

Laura Joszt, MA

Being proactive about identifying potential financial burdens and preparing patients who have a disease for the costs of their treatment helps to ensure that patients will be adherent to their medication and have the best possible outcomes, according to a panel of providers at the Cost-Sharing Roundtable, co-hosted by the Patient Access Network Foundation and The American Journal of Managed Care®.

March 2nd 2018

This Week in Managed Care: March 2, 2018

This week, the top managed care stories included a bipartisan group of governors releasing an outline for health reform; a report finds value-based contracts brings down prescription drug co-pays; 20 states file a lawsuit over the constitutionality of the Affordable Care Act.

March 2nd 2018

AJMC® in the Press, March 2, 2018

AJMC Staff

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

February 28th 2018

Commercial Insurer Spending on Chemotherapy Lower in Physician Offices Versus HOPDs

Jaime Rosenberg

Shifting provisions of infused chemotherapy from physician offices to hospital outpatient departments (HOPDs) is increasing; however spending for commerical insurers was lower for patients treated in physician offices compared with HOPDs, according to a research letter in JAMA Oncology.

February 28th 2018

What Implementing the OCM Looks Like in a Large Practice

Mary Caffrey

Coverage of updates in value from Patient-Centered Oncology Care, November 16-17, 2017.

February 28th 2018

Panel Explores Impact of Novel Therapies on Oncology Stakeholders

Alison Rodriguez

Coverage of value updates from Patient-Centered Oncology Care, November 16-17, 2018.

February 28th 2018

Adopting Real-World Evidence and Value Into a Payment Model

Alison Rodriguez

Coverage of value updates from Patient-Centered Oncology Care, November 16-17, 2018.

February 28th 2018

Using Data on Patients' Cancer Experiences to Change Payment Paradigms

Mary Caffrey

Coverage of patient-centered care updates from Patient-Centered Oncology Care, November 16-17, 2017.

February 28th 2018

Navigators Offer Touch Points on Patients' Cancer Journey

Mary Caffrey

Coverage of patient-centered care from Patient-Centered Oncology Care, November 16-17, 2017.

February 28th 2018

The Importance of Teamwork in Oncology Care Transitions

Surabhi Dangi-Garimella, PhD

Coverage of patient-centered care updates from Patient-Centered Oncology Care, November 16-17, 2017.

...

52 53 54 55 56 57 58 59 60

...

184 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions